PolicyChanges tracks payer policy changes for medical practices and tells you what to do before they take effect.

Create a free accountPolicy Monitoring is free. No card required.
← Back to list
HumanaMedicare Advantage · Prior Auth · Medicaid · FL, SC, IN, OK, VA · Pharmacy, Geriatrics, Psychiatry +4 moreHigh impact

Anticholinergic Polypharmacy Agents (Revised)

Act
by May 13, 2026
Effective date
May 13, 2026
Identified
Jun 25, 2026

Summary

Humana has updated its Anticholinergic Polypharmacy guidance (revised May 13, 2026) to implement a safety edit that restricts concurrent use of multiple anticholinergic medications for members aged 65+, unless the provider attests that benefits outweigh risks per American Geriatrics Society Beers Criteria and provides patient education. Members in hospice are exempt from this restriction. This affects pharmacy claims across Medicare and multiple state Medicaid programs.

Get alerts when payers change rules like this one

We check Humana and other payers every day and email you when a change matches your specialty and state.

Get Humana alertsPolicy Monitoring is free. No card required.

What to do

by May 13, 2026 · 6 steps
01Billing and pharmacy teams must implement the following changes.
02Update pharmacy billing system to flag and apply safety edits for concurrent anticholinergic medications (antihistamines, antiparkinsons, skeletal muscle relaxants, TCAs, paroxetine, antipsychotics, antimuscarinics, antispasmodics, antiemetics) for all members aged 65+ across affected plans.
03Establish prior authorization workflow requiring provider attestation that medical benefits outweigh risks per AGS Beers Criteria and documentation of patient education before approving concurrent anticholinergic polypharmacy.
04Exempt hospice members from the safety edit—ensure system flags reflect hospice status.
05Train providers on attestation requirements and documentation standards.
06Update claim adjudication rules to deny concurrent anticholinergic claims lacking proper provider attestation and patient education documentation.
If missed: Failure to implement will result in inappropriate claim denials and potential quality measure penalties under the Pharmacy Quality Alliance Polypharmacy measure.

Original notice

Anticholinergic Polypharmacy Agents (Revised)
mcp.humana.com · Always check the source before changing claims.
View original ↗

Related policy hubs

Summaries are AI-assisted. Always confirm against the original payer notice.

What is PolicyChanges

One workspace for payer rules, prior auth, coding and compliance

Medical practices use PolicyChanges to catch payer changes before they cause denials. Every change is summarized in plain English, with the codes involved, the date it takes effect and what to do.

Start freePolicy Monitoring is free. No card required.
Get alerts for changes like thisPolicy Monitoring is free. No card required.Create a free account